C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors »

Beam Therapeutics shares owned by C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors from 13F filings

Historical chart of C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $235k 6.8k 34.32
2024-12-31 $584k 13k 43.95

More positions owned by C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors

Spdr Series Trust St Str P500etf (SPYM)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Blackrock Etf Trust Isha In Ctry Etf (CORO)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard Index Fds Value Etf (VTV)
Dimensional Etf Trust World Ex Us Core (DFAX)
Spdr Series Trust ST STR P500GRW (SPYG)
Blackrock Etf Trust Isha I In Te Etf (BAI)
Ishares Tr S&p 500 Val Etf (IVE)
Dimensional Etf Trust Us Cor Equ 1 Etf (DCOR)
Apple (AAPL)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr Msci Usa Mmentm (MTUM)

View all positions for C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors

Top funds holding Beam Therapeutics

FMR
Farallon Capital Management
ARK Investment Management
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Arch Venture Corp
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Kynam Capital Management
T. Rowe Price Associates
Geode Capital Management
Dimensional Fund Advisors
Contrarius Group Holdings

View all funds holding Beam Therapeutics